Latest Developments in Global Laxative Market

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Latest Developments in Global Laxative Market

  • Pharmaceutical
  • Upcoming Report
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In 2022, Roivant Sciences, in collaboration with Pfizer, launched RVT-3101 to tackle ulcerative colitis. Roivant retains commercial rights in the U.S. and Japan, while Pfizer oversees commercialization elsewhere. This partnership aims to combat the global impact of ulcerative colitis through joint commercial efforts
  • In 2022, JB Pharma unveiled Ranraft, a novel treatment for gastroesophageal reflux disease (GERD), bolstering its position in gastroenterology. This strategic launch expands JB Pharma's product portfolio and underscores its dedication to innovative digestive health solutions, catering to the needs of GERD sufferers
  • In 2021, Purdue Pharma L.P. introduced two Senokot Dietary Supplement Products. Senokot Laxative Gummies, in blueberry pomegranate flavor, offer gentle overnight relief for constipation with natural senna extract. Senokot Laxative Tea, infused with cinnamon and floral notes, diversifies their digestive health offerings
  • In 2020, FDA approved lactitol for chronic idiopathic constipation treatment in adults. As a powder, lactitol offers flexibility in administration and is easily mixed with water or juice for enhanced patient convenience. This approval broadens treatment options, providing a versatile solution for chronic constipation sufferers

Frequently Asked Questions

The market is segmented based on Segmentation, By Type (Osmotic Laxatives, Stimulant Laxatives, Bulk Laxatives, and Lubricant and Emollient Laxatives), Flavors (With Flavor and Without Flavor), Source (Natural, Synthetic, and Others), Indication (Chronic Constipation, Irritable Bowel Syndrome with Constipation, Opioid-Induced Constipation, Acute  Constipation, and Others), Mode of Purchase (Prescription, and Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid, Gels, Suppositories, and Others), Route of Administration (Oral, and Rectal), Population Type (Children, and Adults), Sales Channel (Hospitals, Elderly Care Centers, Laxative, Pharmacy Stores, Health and Beauty Stores, and Others), Distribution channel (Direct Sales, Wholesalers, and Others) – Industry Trends and Forecast to 2032 .
The Global Laxative Market size was valued at USD 7.35 USD Billion in 2024.
The Global Laxative Market is projected to grow at a CAGR of 6.3% during the forecast period of 2025 to 2032.
The major players operating in the market include F. Hoffmann La Roche , Mylan N.V., Teva Pharmaceutical Industries , Sanofi, Pfizer , GSK plc, Novartis AG, Merck & Co. , AstraZeneca, Johnson & Johnson Services , Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories , Lupin, Fresenius Kabi AG, Aurobindo Pharma, Cipla , Bausch Health Companies , Amneal Pharmaceuticals LLC., Apotex , Eli Lilly and Company.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.